CalmiGo

Calling all longevity start-ups and scale-ups

Latest articles

Billionaire donates $220m for peak performance research

Salk Institute, UC San Diego and Stanford given $220 million by Wu Tsai Human Performance Alliance to research molecular underpinnings of peak human performance. A Salk...

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. Over the coming weeks, we...

Product review: Bearaby weighted blanket

Bearaby weighted blankets are on a mission to provide you with deep sleep, peace of mind and a joyful feeling.   GO LONG    GO SHORT ...

Aging well: the new human imperative

Prof Andrew Scott touts the importance of compressing morbidity and aging well to realise multi-trillion dollar benefit of increasing life expectancy. Earlier this year, we...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
Seno

Editor's picks

Billionaire donates $220m for peak performance research

Salk Institute, UC San Diego and Stanford given $220 million by Wu Tsai Human Performance Alliance to research molecular underpinnings of peak human performance. A Salk...

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. Over the coming weeks, we...

Product review: Bearaby weighted blanket

Bearaby weighted blankets are on a mission to provide you with deep sleep, peace of mind and a joyful feeling.   GO LONG    GO SHORT ...
CalmiGo

Click the globe for translations.

Some news from us! Longevity.Technology’s brand-new investment portal brings innovators and investors together.

As a part of our mission to support the companies that will form the longevity economy, we have created an investment portal to introduce longevity tech companies to VC funds, family offices, high net worth and sophisticated investors.​

We are delighted to introduce our first investments deals; we have more deals coming online over the coming days/weeks:

  • Occuity: is targeting diabetes and Alzheimer’s Disease with a non-invasive eye-scanner;
  • iamYiam: has just closed its first workplace wellbeing deal for syd, its AI digital twin;
  • PCL Health: is just about to start a trial with the UK NHS for its aging-in-place technology.

Are you looking for early-stage investment?

Our straightforward process allows companies seeking pre-seed to Series A equity finance to complete a short fact-find and submit their decks to our platform. Our team will review your submission to gauge its appeal for our growing cohort of professional investors. Terms and conditions apply.

AppleMac

Although our first deals are UK-based, we are supporting businesses from outside the UK on the platform – we are dealing with US-based businesses in a slightly different way but we encourage companies that are fundraising to complete the 10-minute fact find and upload their deck.

We’ve added the questionnaire below just in case you’re in a hurry:

Step 1 of 7

1. Please tell a little about yourself and your business.

Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. First Longevity is targeted exclusively at sophisticated investors who understand these risks and make their own investment decisions. Investment opportunities have not been approved as financial promotions and are not covered by the Financial Services Compensation Scheme (FSCS) and you may not have access to the Financial Ombudsman Service (FOS). If you are in any doubt about the action you should take or the contents of any of the Financial Promotion received, you should contact your stockbroker, solicitor, accountant, bank manager or other professional adviser authorised under the Financial Services and Markets Act 2000, who specialises in advising on bonds, shares and other securities, including unlisted securities. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.  Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status.

Image courtesy of fauxelsPexels

Comment on this article

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
CalmiGo

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
Seno

Related articles

Billionaire donates $220m for peak performance research

Salk Institute, UC San Diego and Stanford given $220 million by Wu Tsai Human Performance Alliance to research molecular underpinnings of peak human performance. A Salk...

Crypto airdrop swells SENS coffers by $20m – and climbing

Pulse chain airdrop to support longevity research is live – and the numbers are staggering – four times annual budget in just two days. Cryptocurrency...

Crypto auction raises over $5m for longevity research

VitaDAO raises 400% of expectation and will use it to fund longevity research and projects that promote healthspan and lifespan. The world’s first decentralised intellectual...

$18m raise to radically reset expectations for aging

Insurtech Assured Allies raises $18.3m and will apply data and behavioural science to shift the aging trajectory toward healthier longevity. Assured Allies, company working in...

Targeting cellular senescence is a potential $127B market

A vaccine for aging? New report assesses the investment potential of the emerging senotherapeutics sector, reviews companies working in the field, and examines the...
Seno